| Product Code: ETC5359023 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Latvia continued to see a high concentration of buprenorphine import shipments, with top exporters being China, Poland, Ukraine, Germany, and India. Despite a significant growth rate with a CAGR of 47.56% from 2020 to 2024, there was a notable decline in growth from 2023 to 2024 at -41.38%. The high Herfindahl-Hirschman Index (HHI) indicates a competitive market for buprenorphine imports in Latvia, with key players maintaining a strong presence. Continued monitoring of these trends will be crucial for stakeholders in the pharmaceutical industry.

By 2027, Latvia's Buprenorphine market is forecasted to achieve a stable growth rate of 1.03%, with Germany leading the Europe region, followed by United Kingdom, France, Italy and Russia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Buprenorphine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Buprenorphine Market - Industry Life Cycle |
3.4 Latvia Buprenorphine Market - Porter's Five Forces |
3.5 Latvia Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Latvia Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Latvia Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of buprenorphine therapy for opioid addiction treatment |
4.2.2 Rising prevalence of opioid addiction in Latvia |
4.2.3 Government initiatives to improve access to opioid addiction treatment services |
4.3 Market Restraints |
4.3.1 Stringent regulations and licensing requirements for prescribing and dispensing buprenorphine |
4.3.2 High cost of buprenorphine treatment |
4.3.3 Stigma associated with opioid addiction and medication-assisted treatment |
5 Latvia Buprenorphine Market Trends |
6 Latvia Buprenorphine Market Segmentations |
6.1 Latvia Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Latvia Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Latvia Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Latvia Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Latvia Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Latvia Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Latvia Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Latvia Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Latvia Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Latvia Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Latvia Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Latvia Buprenorphine Market Import-Export Trade Statistics |
7.1 Latvia Buprenorphine Market Export to Major Countries |
7.2 Latvia Buprenorphine Market Imports from Major Countries |
8 Latvia Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers trained in buprenorphine prescribing practices |
8.2 Percentage of opioid addiction patients receiving buprenorphine therapy |
8.3 Rate of adherence to buprenorphine treatment protocols |
8.4 Average wait time for patients seeking buprenorphine treatment |
8.5 Number of public awareness campaigns on opioid addiction and buprenorphine therapy |
9 Latvia Buprenorphine Market - Opportunity Assessment |
9.1 Latvia Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Latvia Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Latvia Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Buprenorphine Market - Competitive Landscape |
10.1 Latvia Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Latvia Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here